ALB and obesity disorder: Another smaller randomized clinical trial involving 19 patients with obesity and diabetes and 19 medical controls showed insignificant reduction of urine albumin–creatinine ratio (− 1.0 vs. 0.0 mg/g, P = 0.96) [13].